Array comparative genomic hybridization and cytogenetic analysis in pediatric acute leukemias

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Chromosomal abnormalities are common in acute lymphocytic leukemia (ALL), but conventional cytogenetics misses significant alterations in up to 50% of cases.
• Therapy failures in ALL, even with favorable cytogenetics, highlight the need for more sensitive diagnostic tools.
• Limitations of karyotype analysis include low mitotic rates, apoptosis, normal cell overgrowth, and poor chromosome quality.

Purpose of the Study:

• To evaluate the utility of cytogenetic microarray (molecular karyotyping) in pediatric ALL.
• To compare microarray findings with conventional karyotype results in ALL cases.
• To assess the potential of microarray for improving prognostic accuracy and treatment strategies in ALL.

Main Methods:

• Array comparative genomic hybridization (ACGH) microarray was applied to 9 retrospective pediatric ALL cases.
• Conventional karyotype analysis was performed and compared with the "molecular karyotype" from microarray.
• Analysis focused on identifying unbalanced chromosome rearrangements, copy number gains, and losses.

Main Results:

• Microarray identified previously undetected chromosome losses and gains in pediatric ALL samples.
• Significant discordance was observed between conventional karyotype interpretations and microarray results.
• Molecular karyotyping revealed a more comprehensive genetic profile than classical cytogenetics.

Conclusions:

• Cytogenetic microarray provides higher genomic resolution and sensitivity compared to conventional karyotyping for ALL.
• The complementary use of microarray and conventional cytogenetics enhances the accuracy of genetic profiling.
• Improved diagnostic accuracy through molecular karyotyping holds promise for better prognosis and treatment of ALL and other neoplastic disorders.